Ark Therapeutics Group PLC Results of General Meeting (5202Z)
December 11 2014 - 7:43AM
UK Regulatory
TIDMAKT
RNS Number : 5202Z
Ark Therapeutics Group PLC
11 December 2014
ARK THERAPEUTICS GROUP PLC
Results of General Meeting
London, UK, 11 December 2014 (LSE: AKT): Ark Therapeutics Group
plc ("Ark" or the "Company") announces that at the Company's
General Meeting held earlier today all resolutions were duly
passed. A summary of the votes lodged by proxy is set out
below:
No Resolution Votes for % Discretion % Votes % Votes withheld
against
Proposed transfer
1 to standard list 73,699,781 92.23 6,189,396 7.75 15,237 0.02 38,050
Adoption of 2014
Executive Option
2 Plan 73,692,058 92.25 6,175,245 7.73 17,609 0.02 57,552
Adoption of 2014
3 EMI Plan 73,692,058 92.25 6,175,245 7.73 17,609 0.02 57,552
Approval of
Directors'
remuneration
4 policy 68,157,170 85.39 6,175,245 7.73 5,486,957 6.87 122,552
Approval of the
5 Rule 9 waiver 73,703,875 99.74 175,245 0.24 17,309 0.02 46,053
Approval of the
Terms of the
6 Subscription 73,639,630 92.24 6,175,245 7.73 17,309 0.02 110,550
Authority to
7 allot shares 73,631,243 92.18 6,233,362 7.80 17,309 0.02 60,550
Disapplication
of pre-emption
8 rights 73,627,226 92.16 6,248,362 7.82 17,309 0.02 49,567
Share capital
9 reorganisation 73,605,664 92.12 6,233,362 7.80 65,388 0.08 38,050
Amendments to
Articles of
10 Association 73,558,743 92.16 6,248,513 7.82 17,158 0.02 88,050
11 Name change 73,605,664 92.17 6,233,362 7.81 15,388 0.02 88,050
For further information please contact:
Ark Therapeutics Group plc Tel: +44(0)203 755 5160
Iain G Ross, Non-Executive Chairman
Sue Steven, Non-Executive Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMBDBDDBSBBGSB
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Apr 2023 to Apr 2024